Global and Japan Dendritic Cell Cancer Vaccine Market Insights, Forecast to 2027

Global and Japan Dendritic Cell Cancer Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Dendritic Cell Cancer Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Application
1.3.2 Pediatrics
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dendritic Cell Cancer Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Dendritic Cell Cancer Vaccine Revenue 2016-2027
2.1.2 Global Dendritic Cell Cancer Vaccine Sales 2016-2027
2.2 Global Dendritic Cell Cancer Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Dendritic Cell Cancer Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2022-2027)
3 Global Dendritic Cell Cancer Vaccine Competitor Landscape by Players
3.1 Global Top Dendritic Cell Cancer Vaccine Manufacturers by Sales
3.1.1 Global Dendritic Cell Cancer Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Dendritic Cell Cancer Vaccine Manufacturers by Revenue
3.2.1 Key Dendritic Cell Cancer Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Dendritic Cell Cancer Vaccine Revenue in 2020
3.2.6 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dendritic Cell Cancer Vaccine Price by Manufacturers
3.4 Global Dendritic Cell Cancer Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dendritic Cell Cancer Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dendritic Cell Cancer Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Dendritic Cell Cancer Vaccine Market Size by Type (2016-2021)
4.1.1 Global Dendritic Cell Cancer Vaccine Sales by Type (2016-2021)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Type (2016-2021)
4.1.3 Dendritic Cell Cancer Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Dendritic Cell Cancer Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Dendritic Cell Cancer Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Dendritic Cell Cancer Vaccine Market Size by Application (2016-2021)
5.1.1 Global Dendritic Cell Cancer Vaccine Sales by Application (2016-2021)
5.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Application (2016-2021)
5.1.3 Dendritic Cell Cancer Vaccine Price by Application (2016-2021)
5.2 Dendritic Cell Cancer Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Dendritic Cell Cancer Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Dendritic Cell Cancer Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Dendritic Cell Cancer Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Dendritic Cell Cancer Vaccine Market Share in Global Market 2016-2027
6.2 Japan Dendritic Cell Cancer Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Dendritic Cell Cancer Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Dendritic Cell Cancer Vaccine Players by Revenue (2016-2021)
6.3 Japan Dendritic Cell Cancer Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Dendritic Cell Cancer Vaccine Price by Type (2016-2021)
6.4 Japan Dendritic Cell Cancer Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Dendritic Cell Cancer Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Dendritic Cell Cancer Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Dendritic Cell Cancer Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Dendritic Cell Cancer Vaccine Price by Application (2016-2021)
6.6 Japan Dendritic Cell Cancer Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Dendritic Cell Cancer Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Dendritic Cell Cancer Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
7.2 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
7.2.1 North America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
7.2.2 North America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
9.2.1 Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
9.2.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
10.2.1 Latin America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dendritic Cell Cancer Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Activarti
12.1.1 Activarti Corporation Information
12.1.2 Activarti Description and Business Overview
12.1.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Activarti Dendritic Cell Cancer Vaccine Products Offered
12.1.5 Activarti Recent Development
12.2 Argos Therapeutics
12.2.1 Argos Therapeutics Corporation Information
12.2.2 Argos Therapeutics Description and Business Overview
12.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.2.5 Argos Therapeutics Recent Development
12.3 SOTIO (Acquired by PPF Group)
12.3.1 SOTIO (Acquired by PPF Group) Corporation Information
12.3.2 SOTIO (Acquired by PPF Group) Description and Business Overview
12.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Products Offered
12.3.5 SOTIO (Acquired by PPF Group) Recent Development
12.4 Bellicum Pharmaceuticals
12.4.1 Bellicum Pharmaceuticals Corporation Information
12.4.2 Bellicum Pharmaceuticals Description and Business Overview
12.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Products Offered
12.4.5 Bellicum Pharmaceuticals Recent Development
12.5 JW CreaGene
12.5.1 JW CreaGene Corporation Information
12.5.2 JW CreaGene Description and Business Overview
12.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Products Offered
12.5.5 JW CreaGene Recent Development
12.6 DanDrit
12.6.1 DanDrit Corporation Information
12.6.2 DanDrit Description and Business Overview
12.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 DanDrit Dendritic Cell Cancer Vaccine Products Offered
12.6.5 DanDrit Recent Development
12.7 DCPrime
12.7.1 DCPrime Corporation Information
12.7.2 DCPrime Description and Business Overview
12.7.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 DCPrime Dendritic Cell Cancer Vaccine Products Offered
12.7.5 DCPrime Recent Development
12.8 Elios Therapeutics
12.8.1 Elios Therapeutics Corporation Information
12.8.2 Elios Therapeutics Description and Business Overview
12.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.8.5 Elios Therapeutics Recent Development
12.9 ImmunoCellular Therapeutics
12.9.1 ImmunoCellular Therapeutics Corporation Information
12.9.2 ImmunoCellular Therapeutics Description and Business Overview
12.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Products Offered
12.9.5 ImmunoCellular Therapeutics Recent Development
12.10 Kiromic
12.10.1 Kiromic Corporation Information
12.10.2 Kiromic Description and Business Overview
12.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kiromic Dendritic Cell Cancer Vaccine Products Offered
12.10.5 Kiromic Recent Development
12.11 Activarti
12.11.1 Activarti Corporation Information
12.11.2 Activarti Description and Business Overview
12.11.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Activarti Dendritic Cell Cancer Vaccine Products Offered
12.11.5 Activarti Recent Development
12.12 Merck
12.12.1 Merck Corporation Information
12.12.2 Merck Description and Business Overview
12.12.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck Products Offered
12.12.5 Merck Recent Development
12.13 Northwest Biotherapeutics
12.13.1 Northwest Biotherapeutics Corporation Information
12.13.2 Northwest Biotherapeutics Description and Business Overview
12.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Northwest Biotherapeutics Products Offered
12.13.5 Northwest Biotherapeutics Recent Development
12.14 Immutep Limited
12.14.1 Immutep Limited Corporation Information
12.14.2 Immutep Limited Description and Business Overview
12.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Immutep Limited Products Offered
12.14.5 Immutep Limited Recent Development
12.15 Dendreon Corporation
12.15.1 Dendreon Corporation Corporation Information
12.15.2 Dendreon Corporation Description and Business Overview
12.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Dendreon Corporation Products Offered
12.15.5 Dendreon Corporation Recent Development
12.16 Oncobiomed
12.16.1 Oncobiomed Corporation Information
12.16.2 Oncobiomed Description and Business Overview
12.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Oncobiomed Products Offered
12.16.5 Oncobiomed Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Dendritic Cell Cancer Vaccine Industry Trends
13.2 Dendritic Cell Cancer Vaccine Market Drivers
13.3 Dendritic Cell Cancer Vaccine Market Challenges
13.4 Dendritic Cell Cancer Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dendritic Cell Cancer Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of CreaVax
Table 3. Major Manufacturers of Sipuleucel-T (Provenge)
Table 4. Major Manufacturers of Others
Table 5. Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 6. Global Dendritic Cell Cancer Vaccine Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Dendritic Cell Cancer Vaccine Sales by Regions (2016-2021) & (K Doses)
Table 8. Global Dendritic Cell Cancer Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Dendritic Cell Cancer Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Dendritic Cell Cancer Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 11. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Dendritic Cell Cancer Vaccine Sales by Manufacturers (2016-2021) (K Doses)
Table 15. Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Dendritic Cell Cancer Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Dendritic Cell Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2020)
Table 21. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2016-2021) (USD/Dose)
Table 22. Dendritic Cell Cancer Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) (K Doses)
Table 27. Global Dendritic Cell Cancer Vaccine Sales Share by Type (2016-2021)
Table 28. Global Dendritic Cell Cancer Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2016-2021)
Table 30. Dendritic Cell Cancer Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Dose)
Table 31. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 32. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Dendritic Cell Cancer Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Dendritic Cell Cancer Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Dose)
Table 36. Global Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) (K Doses)
Table 37. Global Dendritic Cell Cancer Vaccine Sales Share by Application (2016-2021)
Table 38. Global Dendritic Cell Cancer Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Dendritic Cell Cancer Vaccine Revenue Share by Application (2016-2021)
Table 40. Dendritic Cell Cancer Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Dose)
Table 41. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 42. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Dendritic Cell Cancer Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Dose)
Table 46. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 47. Japan Dendritic Cell Cancer Vaccine Sales Share by Company (2016-2021)
Table 48. Japan Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Dendritic Cell Cancer Vaccine Revenue Share by Company (2016-2021)
Table 50. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) by Type (2016-2021)
Table 51. Japan Dendritic Cell Cancer Vaccine Sales Share by Type (2016-2021)
Table 52. Japan Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Dendritic Cell Cancer Vaccine Price (USD/Dose) by Type (2016-2021)
Table 54. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) by Type (2022-2027)
Table 55. Japan Dendritic Cell Cancer Vaccine Sales Share by Type (2022-2027)
Table 56. Japan Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Dendritic Cell Cancer Vaccine Revenue Share by Type (2022-2027)
Table 58. Japan Dendritic Cell Cancer Vaccine Price (USD/Dose) by Type (2022-2027)
Table 59. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) by Application (2016-2021)
Table 60. Japan Dendritic Cell Cancer Vaccine Sales Share by Application (2016-2021)
Table 61. Japan Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Dendritic Cell Cancer Vaccine Price (USD/Dose) by Application (2016-2021)
Table 63. Japan Dendritic Cell Cancer Vaccine Sales (K Doses) by Application (2022-2027)
Table 64. Japan Dendritic Cell Cancer Vaccine Sales Share by Application (2022-2027)
Table 65. Japan Dendritic Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Dendritic Cell Cancer Vaccine Revenue Share by Application (2022-2027)
Table 67. Japan Dendritic Cell Cancer Vaccine Price (USD/Dose) by Application (2022-2027)
Table 68. North America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 69. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) & (K Doses)
Table 73. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 77. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 81. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 85. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Activarti Corporation Information
Table 89. Activarti Description and Business Overview
Table 90. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Activarti Dendritic Cell Cancer Vaccine Product
Table 92. Activarti Recent Development
Table 93. Argos Therapeutics Corporation Information
Table 94. Argos Therapeutics Description and Business Overview
Table 95. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Argos Therapeutics Product
Table 97. Argos Therapeutics Recent Development
Table 98. SOTIO (Acquired by PPF Group) Corporation Information
Table 99. SOTIO (Acquired by PPF Group) Description and Business Overview
Table 100. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. SOTIO (Acquired by PPF Group) Product
Table 102. SOTIO (Acquired by PPF Group) Recent Development
Table 103. Bellicum Pharmaceuticals Corporation Information
Table 104. Bellicum Pharmaceuticals Description and Business Overview
Table 105. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Bellicum Pharmaceuticals Product
Table 107. Bellicum Pharmaceuticals Recent Development
Table 108. JW CreaGene Corporation Information
Table 109. JW CreaGene Description and Business Overview
Table 110. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. JW CreaGene Product
Table 112. JW CreaGene Recent Development
Table 113. DanDrit Corporation Information
Table 114. DanDrit Description and Business Overview
Table 115. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. DanDrit Product
Table 117. DanDrit Recent Development
Table 118. DCPrime Corporation Information
Table 119. DCPrime Description and Business Overview
Table 120. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. DCPrime Product
Table 122. DCPrime Recent Development
Table 123. Elios Therapeutics Corporation Information
Table 124. Elios Therapeutics Description and Business Overview
Table 125. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Elios Therapeutics Product
Table 127. Elios Therapeutics Recent Development
Table 128. ImmunoCellular Therapeutics Corporation Information
Table 129. ImmunoCellular Therapeutics Description and Business Overview
Table 130. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. ImmunoCellular Therapeutics Product
Table 132. ImmunoCellular Therapeutics Recent Development
Table 133. Kiromic Corporation Information
Table 134. Kiromic Description and Business Overview
Table 135. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Kiromic Product
Table 137. Kiromic Recent Development
Table 138. Medigene Corporation Information
Table 139. Medigene Description and Business Overview
Table 140. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Medigene Product
Table 142. Medigene Recent Development
Table 143. Merck Corporation Information
Table 144. Merck Description and Business Overview
Table 145. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 146. Merck Product
Table 147. Merck Recent Development
Table 148. Northwest Biotherapeutics Corporation Information
Table 149. Northwest Biotherapeutics Description and Business Overview
Table 150. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 151. Northwest Biotherapeutics Product
Table 152. Northwest Biotherapeutics Recent Development
Table 153. Immutep Limited Corporation Information
Table 154. Immutep Limited Description and Business Overview
Table 155. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 156. Immutep Limited Product
Table 157. Immutep Limited Recent Development
Table 158. Dendreon Corporation Corporation Information
Table 159. Dendreon Corporation Description and Business Overview
Table 160. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 161. Dendreon Corporation Product
Table 162. Dendreon Corporation Recent Development
Table 163. Oncobiomed Corporation Information
Table 164. Oncobiomed Description and Business Overview
Table 165. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 166. Oncobiomed Product
Table 167. Oncobiomed Recent Development
Table 168. Dendritic Cell Cancer Vaccine Market Trends
Table 169. Dendritic Cell Cancer Vaccine Market Drivers
Table 170. Dendritic Cell Cancer Vaccine Market Challenges
Table 171. Dendritic Cell Cancer Vaccine Market Restraints
Table 172. Dendritic Cell Cancer Vaccine Customers List
Table 173. Dendritic Cell Cancer Vaccine Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Dendritic Cell Cancer Vaccine Product Picture
Figure 2. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. CreaVax Product Picture
Figure 4. Sipuleucel-T (Provenge) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. Pediatrics
Figure 8. Adults
Figure 9. Dendritic Cell Cancer Vaccine Report Years Considered
Figure 10. Global Dendritic Cell Cancer Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dendritic Cell Cancer Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Dendritic Cell Cancer Vaccine Sales 2016-2027 (K Doses)
Figure 13. Global Dendritic Cell Cancer Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2020
Figure 16. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Figure 17. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2020
Figure 18. Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2020
Figure 20. Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Figure 22. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020
Figure 23. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
Figure 24. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type in 2020
Figure 25. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs